US Stock MarketDetailed Quotes

AYTU Aytu BioPharma

Watchlist
  • 1.2400
  • -0.0100-0.80%
Close Mar 21 16:00 ET
  • 1.2400
  • 0.00000.00%
Post 20:01 ET
7.65MMarket Cap-0.71P/E (TTM)

Aytu BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Dec 31, 2024
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
2,128.89%2.74M
-463.98%-1.19M
72.94%-1.39M
-108.41%-788K
91.26%-254K
94.47%-135K
97.69%-211K
82.21%-5.13M
231.99%9.37M
68.12%-2.91M
Net income from continuing operations
458.18%788K
118.15%1.47M
7.08%-15.84M
-87.91%-4.62M
59.90%-2.89M
96.71%-220K
-1,058.35%-8.12M
84.33%-17.05M
84.73%-2.46M
86.49%-7.2M
Operating gains losses
-622.70%-3.02M
-148.76%-2.88M
191.88%4.4M
-177.37%-1.06M
60.47%-1.02M
141.13%577K
369.60%5.91M
-1,184.99%-4.79M
1,060.84%1.37M
-1,329.44%-2.57M
Depreciation and amortization
-34.51%1.17M
-22.57%1.43M
-6.16%8.27M
-8.13%1.94M
22.90%2.69M
-18.81%1.79M
-19.90%1.84M
-13.12%8.82M
-4.68%2.12M
-14.84%2.19M
Other non cash items
-21.61%544K
-181.47%-598K
411.91%1.26M
398.23%844K
-60.60%-1.02M
183.27%694K
174.91%734K
78.17%-403K
61.96%-283K
46.71%-632K
Change In working capital
187.89%3.24M
36.79%-854K
19.64%-4.66M
-101.71%-42K
-90.28%417K
-49.63%-3.68M
86.60%-1.35M
46.62%-5.8M
139.57%2.46M
222.48%4.29M
-Change in receivables
-2,025.42%-2.27M
128.38%478K
174.37%5.32M
21.73%6.31M
106.80%578K
-95.04%118K
72.89%-1.68M
-209.49%-7.15M
-11.96%5.18M
-87.29%-8.5M
-Change in inventory
191.67%627K
129.79%334K
19.42%-2.91M
-98.39%-1.23M
116.29%131K
-765.82%-684K
46.72%-1.12M
-377.83%-3.61M
-151.49%-622K
-222.00%-804K
-Change in prepaid assets
38.47%-798K
-74.52%119K
80.50%1.53M
-85.08%664K
68.79%1.69M
53.76%-1.3M
125.93%467K
-62.03%846K
441.24%4.45M
-69.62%1M
-Change in payables and accrued expense
300.95%5.5M
52.95%-1.83M
-307.81%-12.45M
-20.43%-5.74M
-100.75%-95K
-40.11%-2.74M
-3,761.32%-3.88M
128.56%5.99M
66.29%-4.76M
530.81%12.6M
-Change in other working capital
-79.76%185K
-99.16%41K
305.50%3.85M
97.48%-45K
-26,900.00%-1.89M
22,950.00%914K
6,861.11%4.87M
-3,844.00%-1.87M
-89,350.00%-1.79M
-800.00%-7K
Cash from discontinued investing activities
Operating cash flow
2,251.85%2.91M
-463.98%-1.19M
72.94%-1.39M
-108.41%-788K
91.26%-254K
94.47%-135K
97.69%-211K
82.21%-5.13M
231.99%9.37M
68.12%-2.91M
Investing cash flow
Cash flow from continuing investing activities
183.33%145K
601.32%381K
-181.20%-329K
78.06%-34K
-4,600.00%-45K
-3,380.00%-174K
-280.95%-76K
96.40%-117K
-278.05%-155K
101.43%1K
Net PPE purchase and sale
--145K
--381K
----
----
----
--0
--0
----
----
----
Net other investing changes
----
----
-181.20%-329K
78.06%-34K
-1,025.00%-45K
---174K
-280.95%-76K
-67.14%-117K
-15,400.00%-155K
90.24%-4K
Cash from discontinued investing activities
Investing cash flow
183.33%145K
601.32%381K
-181.20%-329K
78.06%-34K
-4,600.00%-45K
-3,380.00%-174K
-280.95%-76K
96.40%-117K
-278.05%-155K
101.43%1K
Financing cash flow
Cash flow from continuing financing activities
-2,090.48%-2.76M
133.32%911K
-114.23%-1.26M
119.76%1.07M
-79.48%530K
93.24%-126K
-120.17%-2.73M
479.80%8.87M
-383.80%-5.4M
69.82%2.58M
Net issuance payments of debt
-241.04%-723K
481.35%1.41M
19.44%-1.89M
79.26%-1.84M
-81.73%530K
66.46%-212K
-108.71%-370K
55.07%-2.35M
-2,304.73%-8.86M
159.83%2.9M
Net common stock issuance
----
----
-77.74%3.47M
31.92%3.38M
--0
----
----
33.19%15.58M
354.77%2.56M
-81.73%1.44M
Net other financing activities
---2.04M
78.85%-500K
34.86%-2.84M
-153.01%-475K
--0
--0
-113.55%-2.36M
11.82%-4.36M
274.66%896K
-16.74%-1.76M
Cash from discontinued financing activities
Financing cash flow
-2,090.48%-2.76M
133.32%911K
-114.23%-1.26M
119.76%1.07M
-79.48%530K
93.24%-126K
-120.17%-2.73M
479.80%8.87M
-383.80%-5.4M
69.82%2.58M
Net cash flow
Beginning cash position
0.72%20.11M
-12.96%20.01M
18.72%22.99M
3.03%19.76M
0.14%19.53M
-16.16%19.96M
18.72%22.99M
-61.20%19.36M
-30.54%19.18M
-44.72%19.5M
Current changes in cash
166.67%290K
103.38%102K
-182.18%-2.98M
-93.54%246K
171.74%231K
89.91%-435K
-167.87%-3.02M
111.87%3.63M
146.12%3.81M
95.80%-322K
End cash Position
4.45%20.4M
0.72%20.11M
-12.96%20.01M
-12.96%20.01M
3.03%19.76M
0.14%19.53M
-16.16%19.96M
18.72%22.99M
18.72%22.99M
-30.54%19.18M
Free cash flow
2,247.41%2.9M
-528.44%-1.33M
72.94%-1.39M
-108.41%-788K
91.26%-254K
94.47%-135K
97.69%-211K
82.21%-5.13M
231.99%9.37M
68.12%-2.91M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Dec 31, 2024(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 2,128.89%2.74M-463.98%-1.19M72.94%-1.39M-108.41%-788K91.26%-254K94.47%-135K97.69%-211K82.21%-5.13M231.99%9.37M68.12%-2.91M
Net income from continuing operations 458.18%788K118.15%1.47M7.08%-15.84M-87.91%-4.62M59.90%-2.89M96.71%-220K-1,058.35%-8.12M84.33%-17.05M84.73%-2.46M86.49%-7.2M
Operating gains losses -622.70%-3.02M-148.76%-2.88M191.88%4.4M-177.37%-1.06M60.47%-1.02M141.13%577K369.60%5.91M-1,184.99%-4.79M1,060.84%1.37M-1,329.44%-2.57M
Depreciation and amortization -34.51%1.17M-22.57%1.43M-6.16%8.27M-8.13%1.94M22.90%2.69M-18.81%1.79M-19.90%1.84M-13.12%8.82M-4.68%2.12M-14.84%2.19M
Other non cash items -21.61%544K-181.47%-598K411.91%1.26M398.23%844K-60.60%-1.02M183.27%694K174.91%734K78.17%-403K61.96%-283K46.71%-632K
Change In working capital 187.89%3.24M36.79%-854K19.64%-4.66M-101.71%-42K-90.28%417K-49.63%-3.68M86.60%-1.35M46.62%-5.8M139.57%2.46M222.48%4.29M
-Change in receivables -2,025.42%-2.27M128.38%478K174.37%5.32M21.73%6.31M106.80%578K-95.04%118K72.89%-1.68M-209.49%-7.15M-11.96%5.18M-87.29%-8.5M
-Change in inventory 191.67%627K129.79%334K19.42%-2.91M-98.39%-1.23M116.29%131K-765.82%-684K46.72%-1.12M-377.83%-3.61M-151.49%-622K-222.00%-804K
-Change in prepaid assets 38.47%-798K-74.52%119K80.50%1.53M-85.08%664K68.79%1.69M53.76%-1.3M125.93%467K-62.03%846K441.24%4.45M-69.62%1M
-Change in payables and accrued expense 300.95%5.5M52.95%-1.83M-307.81%-12.45M-20.43%-5.74M-100.75%-95K-40.11%-2.74M-3,761.32%-3.88M128.56%5.99M66.29%-4.76M530.81%12.6M
-Change in other working capital -79.76%185K-99.16%41K305.50%3.85M97.48%-45K-26,900.00%-1.89M22,950.00%914K6,861.11%4.87M-3,844.00%-1.87M-89,350.00%-1.79M-800.00%-7K
Cash from discontinued investing activities
Operating cash flow 2,251.85%2.91M-463.98%-1.19M72.94%-1.39M-108.41%-788K91.26%-254K94.47%-135K97.69%-211K82.21%-5.13M231.99%9.37M68.12%-2.91M
Investing cash flow
Cash flow from continuing investing activities 183.33%145K601.32%381K-181.20%-329K78.06%-34K-4,600.00%-45K-3,380.00%-174K-280.95%-76K96.40%-117K-278.05%-155K101.43%1K
Net PPE purchase and sale --145K--381K--------------0--0------------
Net other investing changes ---------181.20%-329K78.06%-34K-1,025.00%-45K---174K-280.95%-76K-67.14%-117K-15,400.00%-155K90.24%-4K
Cash from discontinued investing activities
Investing cash flow 183.33%145K601.32%381K-181.20%-329K78.06%-34K-4,600.00%-45K-3,380.00%-174K-280.95%-76K96.40%-117K-278.05%-155K101.43%1K
Financing cash flow
Cash flow from continuing financing activities -2,090.48%-2.76M133.32%911K-114.23%-1.26M119.76%1.07M-79.48%530K93.24%-126K-120.17%-2.73M479.80%8.87M-383.80%-5.4M69.82%2.58M
Net issuance payments of debt -241.04%-723K481.35%1.41M19.44%-1.89M79.26%-1.84M-81.73%530K66.46%-212K-108.71%-370K55.07%-2.35M-2,304.73%-8.86M159.83%2.9M
Net common stock issuance ---------77.74%3.47M31.92%3.38M--0--------33.19%15.58M354.77%2.56M-81.73%1.44M
Net other financing activities ---2.04M78.85%-500K34.86%-2.84M-153.01%-475K--0--0-113.55%-2.36M11.82%-4.36M274.66%896K-16.74%-1.76M
Cash from discontinued financing activities
Financing cash flow -2,090.48%-2.76M133.32%911K-114.23%-1.26M119.76%1.07M-79.48%530K93.24%-126K-120.17%-2.73M479.80%8.87M-383.80%-5.4M69.82%2.58M
Net cash flow
Beginning cash position 0.72%20.11M-12.96%20.01M18.72%22.99M3.03%19.76M0.14%19.53M-16.16%19.96M18.72%22.99M-61.20%19.36M-30.54%19.18M-44.72%19.5M
Current changes in cash 166.67%290K103.38%102K-182.18%-2.98M-93.54%246K171.74%231K89.91%-435K-167.87%-3.02M111.87%3.63M146.12%3.81M95.80%-322K
End cash Position 4.45%20.4M0.72%20.11M-12.96%20.01M-12.96%20.01M3.03%19.76M0.14%19.53M-16.16%19.96M18.72%22.99M18.72%22.99M-30.54%19.18M
Free cash flow 2,247.41%2.9M-528.44%-1.33M72.94%-1.39M-108.41%-788K91.26%-254K94.47%-135K97.69%-211K82.21%-5.13M231.99%9.37M68.12%-2.91M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+5.27%
Apple
AAPL
+1.95%
Meta Platforms
META
+1.75%
Microsoft
MSFT
+1.14%
Petroleo Brasileiro SA Petrobras
PBR
+0.93%

Unlock the Full List